Lem Moyé

2.2k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Lem Moyé is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Lem Moyé has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Genetics. Recurrent topics in Lem Moyé's work include Mesenchymal stem cell research (5 papers), Meta-analysis and systematic reviews (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Lem Moyé is often cited by papers focused on Mesenchymal stem cell research (5 papers), Meta-analysis and systematic reviews (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). Lem Moyé collaborates with scholars based in United States, Belgium and France. Lem Moyé's co-authors include Milton Packer, Niki E. Kantrowitz, Stephen S. Gottlieb, Josephine Sollano, Patricia McEwan, Peggy Hamm, Edward J. Brown, Lofty L. Basta, Richard M. Steingart and Bernard J. Gersh and has published in prestigious journals such as New England Journal of Medicine, Circulation and PLoS ONE.

In The Last Decade

Lem Moyé

18 papers receiving 1.2k citations

Hit Papers

Sex Differences in the Management of Coronary Artery Disease 1991 2026 2002 2014 1991 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lem Moyé United States 11 712 339 155 146 139 18 1.3k
Niti R. Aggarwal United States 18 742 1.0× 302 0.9× 66 0.4× 150 1.0× 72 0.5× 62 1.3k
Gerard Devlin New Zealand 20 1.1k 1.5× 493 1.5× 401 2.6× 342 2.3× 86 0.6× 75 1.7k
Timothy E. Paterick United States 17 720 1.0× 217 0.6× 118 0.8× 209 1.4× 106 0.8× 68 1.1k
Eric Wallace United States 23 191 0.3× 135 0.4× 169 1.1× 72 0.5× 201 1.4× 83 1.6k
Adin‐Cristian Andrei United States 24 1.0k 1.5× 638 1.9× 139 0.9× 115 0.8× 58 0.4× 119 2.2k
J. W. P. F. Kardaun Netherlands 18 230 0.3× 250 0.7× 40 0.3× 79 0.5× 116 0.8× 37 1.1k
Jacqueline Brown United Kingdom 20 271 0.4× 129 0.4× 128 0.8× 107 0.7× 131 0.9× 50 1.4k
Helén Sjöland Sweden 19 707 1.0× 280 0.8× 166 1.1× 127 0.9× 75 0.5× 55 1.2k
Xavier Armoiry France 24 257 0.4× 291 0.9× 85 0.5× 59 0.4× 38 0.3× 88 1.5k
Geert Frederix Netherlands 16 323 0.5× 124 0.4× 86 0.6× 65 0.4× 52 0.4× 61 945

Countries citing papers authored by Lem Moyé

Since Specialization
Citations

This map shows the geographic impact of Lem Moyé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lem Moyé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lem Moyé more than expected).

Fields of papers citing papers by Lem Moyé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lem Moyé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lem Moyé. The network helps show where Lem Moyé may publish in the future.

Co-authorship network of co-authors of Lem Moyé

This figure shows the co-authorship network connecting the top 25 collaborators of Lem Moyé. A scholar is included among the top collaborators of Lem Moyé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lem Moyé. Lem Moyé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Xiaoyin, Ronak Derakhshandeh, Dmitry Kostyushev, et al.. (2020). Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials. PLoS ONE. 15(8). e0237401–e0237401. 2 indexed citations
2.
Bolli, Roberto, Joshua M. Hare, Timothy D. Henry, et al.. (2018). Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. American Heart Journal. 201. 54–62. 19 indexed citations
3.
Moyé, Lem & Michelle Cohen. (2018). Liberation From the P Value’s Tyranny. Circulation Research. 122(8). 1046–1048. 2 indexed citations
4.
Jokerst, Jesse V., Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.. (2017). Circulating Biomarkers to Identify Responders in Cardiac Cell therapy. Scientific Reports. 7(1). 4419–4419. 20 indexed citations
5.
Traverse, Jay H., Timothy D. Henry, Carl J. Pepine, et al.. (2017). TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function. Circulation Research. 122(3). 479–488. 41 indexed citations
6.
Orozco, Aaron, Robert C. Schutt, Jay H. Traverse, et al.. (2016). Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials. Basic Research in Cardiology. 112(1). 3–3. 11 indexed citations
7.
Moyé, Lem. (2016). Statistical Methods for Cardiovascular Researchers. Circulation Research. 118(3). 439–453. 25 indexed citations
9.
Park, Ki, Eileen Handberg, Lem Moyé, et al.. (2016). Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy. Texas Heart Institute Journal. 43(4). 291–296. 1 indexed citations
10.
Deplanque, G., Martin Demarchi, Mohamed Hebbar, et al.. (2015). A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer. Annals of Oncology. 26(6). 1194–1200. 78 indexed citations
11.
Moyé, Lem. (2015). What can we do about exploratory analyses in clinical trials?. Contemporary Clinical Trials. 45(Pt B). 302–310. 10 indexed citations
12.
Golpanian, Samuel, Ivonne Hernandez Schulman, Ray F. Ebert, et al.. (2015). Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease. Stem Cells Translational Medicine. 5(2). 186–191. 94 indexed citations
13.
Perin, Emerson C., Michael P. Murphy, John P. Cooke, et al.. (2014). Rationale and Design for PACE: Patients with Intermittent Claudication Injected with ALDH Bright Cells. American Heart Journal. 168(5). 667–673.e2. 19 indexed citations
14.
Moyé, Lem. (2014). DAMASCENE and Meta-Ecological Research. Circulation Research. 115(5). 484–487. 9 indexed citations
15.
Moyé, Lem. (2014). Clinical Trials in Cardiology. Circulation Research. 114(1). 28–31. 4 indexed citations
16.
Tonelli, Marcello, Lem Moyé, F M Sacks, B. Kiberd, & Gary C. Curhan. (2003). Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. ACC Current Journal Review. 12(3). 32–32. 7 indexed citations
17.
Hall, Christian, Jean-Lucien Rouleau, Lem Moyé, et al.. (1994). N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.. Circulation. 89(5). 1934–1942. 203 indexed citations
18.
Steingart, Richard M., Milton Packer, Peggy Hamm, et al.. (1991). Sex Differences in the Management of Coronary Artery Disease. New England Journal of Medicine. 325(4). 226–230. 731 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026